Targeted interventions have a more significant impact on quality improvement and cost containment than broader approaches.
Targeting treatments for suitable patients is becoming increasingly important in medical science and is essential for promoting quality and value. Using predictors like high utilization, condition complexity, or other clinical and personal characteristics may improve the returns on delivery system investments. According to research, certain groups, such as people with multiple chronic diseases, low-income and minority populations, and patients in care transitions, are especially vulnerable and more likely to benefit from specific interventions. Targeted interventions have a more significant impact on quality improvement and cost containment than broader approaches.
Furthermore, chronic care management significantly impacts frail patients and those with multiple chronic diseases through improved health outcomes, patient and family satisfaction, and cost savings. Unfortunately, these groups frequently have the least access to good care management programs. Better evidence and analytic capabilities for appropriately targeting delivery system interventions will be significant for future reforms.